Farmington

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Bladder cancer1 trial
• Cervical cancer1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Metastatic breast cancer1 trial
• Neuroendocrine tumours1 trial
• and 5 more

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• AstraZeneca3 trials

Running trials

• Recruiting

  DESTINY-PANTUMOUR04

  NCT07124000· AstraZeneca· Source

• Active, not recruiting

  Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

  NCT04305496· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Cervical cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Neuroendocrine tumours1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Sarcoma1 recruiting
• Thyroid cancer1 recruiting

Closed trials

• Completed

  Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)

  NCT03373045· AstraZeneca· Source